Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Hospital Tübingen | UNKNOWN |
| DFG - Deutsche Forschungs Gemeinschaft (German Research Foundation) | UNKNOWN |
| Mini Research Training Group (MRTG) | UNKNOWN |
Not provided
Not provided
Not provided
The ovarian hormone estradiol (E2) is suspected to have a neuroprotective effect on the brain. Further, it is associated with mental health and brain plasticity, function and connectivity. During the menstrual cycle, women experience fluctuation of E2. This is closely associate with neuroplasticity in regions with high estradiol receptor density, such as the hippocampus, anterior cingulate cortex, amygdala, hypothalamus, or the striatum. In the current study we are interested on the effects of E2 on the brain age, indicated by the comparison between the chronological age and the predicted brain age. In a double-blind within-subject study design, naturally cycling females during their follicular menstrual cycle phase (when their endogenous ovarian hormone levels are low) were either administered estradiol valerate (E2) or a placebo (PLAC) to rapidly increase E2 levels independent of other cycling ovarian hormones. Structural brain scans were assessed.
In this project we assessed regularly cycling females in their early follicular menstrual cycle phase with/without experimentally elevated estradiol (E2) levels in order to examine E2's effect on the brain age. Thus, women were scanned twice in the MR-scanner (E2 vs. PLAC; separated by at least 2-3 months) to deduce underlying structural changes. E2 vs. PLAC were administered in a double-blind, counterbalanced, randomized order. E2 has been administered orally (in total 12mg; two doses à 6mg on two consecutive days). All participants additionally underwent a neuropsychological assessment (demographical data, psychological and clinical data: structured clinical interview, anxiety and depression traits, mood, verbal intelligence, cognitive flexibility, emotion regulation traits, self-esteem). Blood samples were taken to assess endogenous gonadal hormone levels before and after E2/PLAC intake.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Naturally cycling women | Naturally cycling women during the early follicular menstrual cycle phase |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| E2 Valerate | Drug | To experimentally elevate E2 levels females received 6mg of E2 valerate (Progynova21©) on two consecutive days (in total 12mg). |
|
| Measure | Description | Time Frame |
|---|---|---|
| Association between E2 administration and brain age | Assessed via anatomical MRI scans after E2 and PLAC administration. Predicted brain age during the E2- and the PLAC-condition will be compared to the chronological age. | Females were measured twice with at least two-three months apart; each time: approx. 10 minutes assessment of MRI-scans |
| Association between E2 level and brain age. | Assessed via anatomical MRI scans after E2 and PLAC administration and corresponding hormone levels. Association of E2-level increase with the difference between the predicted brain age and the chronological age ("brain-age-gap", BAG) will be compared. | Females were measured twice with at least two-three months apart; each time: approx. 10 minutes assessment of MRI-scans |
| Measure | Description | Time Frame |
|---|---|---|
| Association between progesterone level and brain age. | Assessed via anatomical MRI scans after E2 and PLAC administration and corresponding hormone levels. Association of progesterone levels [nmol/l] with the BAG [years] will be assessed. | Females were measured twice with at least two-three months apart; each time: approx. 10 minutes assessment of MRI-scans |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Present or past mental, neurological or endocrine disorders, neurological or head injuries
Use of hormonal contraceptives during the last six months
Any other medication intake including intake of antidepressants or neuroleptics
Past and present pregnancies
Contraindication for MRI such as:
Not provided
Not provided
The study population mainly consists of residents of Tübingen and surrounding areas.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Birgit Derntl, Prof. | Departement of Psychiatry & Psychotherapy | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Tuebingen; Department of Psychiatry & Psychotherapy | Tübingen | Baden-Wurttemberg | 72076 | Germany |
Not provided
Not provided
Not provided
Not provided
| Placebo | Drug | Placebo pills (blue-colored hard gelatine capsules filled with a mixture of 99.5% mannitol and 0.5% Aerosil (fumed silica)) have been administered for the placebo-controlled condition. |
|
| Association between testosterone level and brain age | Assessed via anatomical MRI scans after E2 and PLAC administration and corresponding hormone levels. Association of testosterone levels [nmol/l] with the BAG [years] will be assessed. | Females were measured twice with at least two-three months apart; each time: approx. 10 minutes assessment of MRI-scans |
| Association between subjective mood and brain age. | Assessed via anatomical MRI scans after E2 and PLAC administration and mood ratings. Association of mood ratings [Positive and negative affect PANAS, ratings from 1 to 5] with the BAG [years] will be assessed. | Females were measured twice with at least two-three months apart; each time: approx. 10 minutes assessment of MRI-scans |
| Association between depression scores and brain age | Assessed via anatomical MRI scans after E2 and PLAC administration and depression scores. Association of depression scores [Becks depression index BDI] with the BAG [years] will be assessed. | Females were measured twice with at least two-three months apart; each time: approx. 10 minutes assessment of MRI-scans |
| Association between anxiety scores and brain age | Assessed via anatomical MRI scans after E2 and PLAC administration and anxiety scores. Association of anxiety scores [State anxiety index STAI] with the BAG [years] will be assessed. | Females were measured twice with at least two-three months apart; each time: approx. 10 minutes assessment of MRI-scans |
| Association between self-esteem and brain age | Assessed via anatomical MRI scans after E2 and PLAC administration and self-esteem scores. Association of self-esteem scores [Rosenberg selfesteem] with the BAG [years] will be assessed. | Females were measured twice with at least two-three months apart; each time: approx. 10 minutes assessment of MRI-scans |
| Association between emotion-regulation and brain age. | Assessed via anatomical MRI scans after E2 and PLAC administration and emotion-regulation scores. Association of emotion-regulation [Heidelberg form of emotion regulation HFRST and emotion regulation questionnaire ERQ] scores with the BAG [years] will be assessed. | Females were measured twice with at least two-three months apart; each time: approx. 10 minutes assessment of MRI-scans |